Back to Search
PATRICE BURCH MD
MD
Family Medicine Physician
NPI: 1679508071IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine Physician
Emergency Medicine
Code: 207P00000X
036-115-400(IL)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
036-115400(IL)
Education
MIDWESTERN UNIVERSITY, CHICAGO COLLEGE OF OSTEOPATHIC MED
Class of 2002
Research & Publications (20)
Mortality in murine peritonitis correlates with increased Escherichia coli adherence to the intestinal mucosa.
PMID 15098788·Am Surg·2004
4-observational
Stentless porcine valves in the right ventricular outflow tract: improved durability?
PMID 19211257·Eur J Cardiothorac Surg·2009
7-preclinical
Mobile phones in hospital. Resurgence in memorial postmortem photography?
PMID 19293207·BMJ·2009
8-other
Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer.
PMID 19536890·Cancer·2009
3-trial
Prostate-specific antigen progression predicts overall survival in patients with metastatic prostate cancer: data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916.
PMID 19380444·J Clin Oncol·2009
3-trial
A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.
PMID 17320666·Urology·2007
3-trial
Predictors of survival from urachal cancer: a Mayo Clinic study of 49 cases.
PMID 17932892·Cancer·2007
8-other
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors.
PMID 16502355·Invest New Drugs·2006
3-trial
Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling.
PMID 16461457·Proc Natl Acad Sci U S A·2006
7-preclinical
Quality of life and pain in advanced stage prostate cancer: results of a Southwest Oncology Group randomized trial comparing docetaxel and estramustine to mitoxantrone and prednisone.
PMID 16782921·J Clin Oncol·2006
2-rct
Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16.
PMID 16622120·J Natl Cancer Inst·2006
8-other
SHP-2 activates signaling of the nuclear factor of activated T cells to promote skeletal muscle growth.
PMID 17015617·J Cell Biol·2006
7-preclinical
A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
PMID 15754203·Cancer Chemother Pharmacol·2005
3-trial
Is bortezomib, a proteasome inhibitor, effective in treating cancer-associated weight loss? Preliminary results from the North Central Cancer Treatment Group.
PMID 15759136·Support Care Cancer·2005
4-observational
Phase II study of gemcitabine plus cisplatin in patients with metastatic breast cancer: a North Central Cancer Treatment Group Trial.
PMID 15803016·Am J Clin Oncol·2005
3-trial
Intratumoral administration of a 1,2-dimyristyloxypropyl-3- dimethylhydroxyethyl ammonium bromide/dioleoylphosphatidylethanolamine formulation of the human interleukin-2 gene in the treatment of metastatic renal cell carcinoma.
PMID 15517589·Cancer·2004
3-trial
An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry.
PMID 15143165·Mol Cell Biol·2004
7-preclinical
Genomic analysis of the nuclear receptor family: new insights into structure, regulation, and evolution from the rat genome.
PMID 15059999·Genome Res·2004
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9831 S WESTERN AVE
CHICAGO, IL 60643 - Phone
- (773) 445-3500
Quick Facts
- NPI
- 1679508071
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 24
- Publications
- 20
Are you this provider?
Claim Your Profile